Skip to main content

Table 1 Descriptive table of demographic variables of ME/CFS patients and controls

From: Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms

Characteristics

Controls (n = 50)

ME/CFS (n = 50)

Total (n = 100)

Females

Males

Females

Males

Females

Males

Sex (n)

25 (50%)

25 (50%)

25 (50%)

25 (50%)

50 (50%)

50 (50%)

Age (Mean \( \mp \)SD)

44.7 (12.2)

34.5 (9.7)

48.4 (9.9)

38.7 (12.9)

46.6 (11.2)

36.6 (11.5)

BMI \( \mp \) (Mean \( \mp \) SD)

27.2 (2.8)

27.4 (3.6)

26.9 (4.9)

26.2 (4.7)

27.0 (4.0)

26.8 (4.2)

Race/ethnicity

 Caucasian (n)

17 (34%)

18 (36%)

23 (46%)

20 (40%)

40 (40%)

38 (38%)

 Non-caucasian (n)

8 (16%)

7 (14%)

2 (4%)

5 (10%)

10 (20%)

12 (24%)

Symptoms

 Fatigue (n)

0

1 (2%)

21 (42%)***

23 (46%)***

21 (21%)

24 (24%)

 Physical pain (n)

2 (4%)

8 (16%)

24 (48%)***

18 (36%)***

26 (26%)

26 (26%)

 Headache (n)

2 (4%)

0

18 (36%)***

14 (34%)***

20 (20%)

14 (14%)

 Cognitive difficulties (n)

0

1 (2%)

17 (34%)***

23 (46%)***

17 (17%)

24 (24%)

Supplement

 DHA (n)

1 (2%)

1 (2%)

5 (10%)

3 (6%)

6 (6%)

4 (4%)

  1. Fisher exact test was used to calculate p-values
  2. *** p-value < 0.001 for the comparison of CFS patients versus their respective controls